NCT02887079View on ClinicalTrials.gov

Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Infective Endocarditis
Trial Locations (2)

Unknown

CHU de Besancon, Besançon

CHU de Nancy, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT02887079 - Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis | Biotech Hunter | Biotech Hunter